Resources

The addition of a vitamin-D receptor activator, paricalcitol (Zemplar, Abbott Laboratories), to therapy in patients with diabetic nephropathy reduces albuminuria and risk of kidney failure….

A controlled resistance exercise program without weight loss increases strength and lean body mass, improves hepatic insulin sensitivity, and decreases GPR without affecting total fat mass or visceral, hepatic, and intramyocellular fat contents….

A pill combining saxagliptin (Onglyza) and extended-release metformin as a once-daily diabetes medication has won FDA approval….

At a time when patients are increasingly turning to social media such as Facebook for information about medical conditions and their treatment, a new study raises disturbing questions about the accuracy of the information on these sites….

Research on insulin-sensitizers can pave the way to identifying a novel therapeutic strategy for the management of prostatic enlargement in insulin-resistant individuals….

Beginning dialysis therapy earlier in the development of advanced kidney disease appears to be associated with a greater risk of death for some patients in the following year, according to a report….

Vitamins and supplements in the U.S. are big business: half of all Americans routinely take them at the rate of about $23 billion dollars every year….

A narrow threshold range for diabetes-specific retinopathy was identified for FPG and HbA1c….

Relationships with drug manufacturers, device companies and other medical companies appear to have decreased since 2004 but remain common among physicians, according to a new report in JAMA….

The slides in this section provide an overview of the classification, etiology, and diagnostic criteria for Type 1 and Type 2 diabetes.